AAAAAA

   
Results: 1-9 |
Results: 9
BASIC THERAPIES IN CYSTIC-FIBROSIS - DOES STANDARD THERAPY WORK
Authors: MARSHALL BC SAMUELSON WM
Citation: Bc. Marshall et Wm. Samuelson, BASIC THERAPIES IN CYSTIC-FIBROSIS - DOES STANDARD THERAPY WORK, Clinics in chest medicine, 19(3), 1998, pp. 487
INDUCTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR BY IL-1-BETA
Authors: HASEGAWA T SORENSEN L DOHI M RAO NV HOIDAL JR MARSHALL BC
Citation: T. Hasegawa et al., INDUCTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR BY IL-1-BETA, American journal of respiratory cell and molecular biology, 16(6), 1997, pp. 683-692
TYLOXAPOL INHIBITS NF-KAPPA-B AND CYTOKINE RELEASE, SCAVENGES HOCL, AND REDUCES VISCOSITY OF CYSTIC-FIBROSIS SPUTUM
Authors: GHIO AJ MARSHALL BC DIAZ JL HASEGAWA T SAMUELSON W POVIA D KENNEDY TP PIANTADOSI CA
Citation: Aj. Ghio et al., TYLOXAPOL INHIBITS NF-KAPPA-B AND CYTOKINE RELEASE, SCAVENGES HOCL, AND REDUCES VISCOSITY OF CYSTIC-FIBROSIS SPUTUM, American journal of respiratory and critical care medicine, 154(3), 1996, pp. 783-788
BIOSYNTHESIS AND PROCESSING OF PROTEINASE-3 IN U937 CELLS - PROCESSING PATHWAYS ARE DISTINCT FROM THOSE OF CATHEPSIN-G
Authors: RAO NV RAO GV MARSHALL BC HOIDAL JR
Citation: Nv. Rao et al., BIOSYNTHESIS AND PROCESSING OF PROTEINASE-3 IN U937 CELLS - PROCESSING PATHWAYS ARE DISTINCT FROM THOSE OF CATHEPSIN-G, The Journal of biological chemistry, 271(6), 1996, pp. 2972-2978
INCREASED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA ISOFORMS (BETA(1), BETA(2), BETA(3)) IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS
Authors: SANTANA A SAXENA B NOBLE NA GOLD LI MARSHALL BC
Citation: A. Santana et al., INCREASED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA ISOFORMS (BETA(1), BETA(2), BETA(3)) IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS, American journal of respiratory cell and molecular biology, 13(1), 1995, pp. 34-44
PATHOPHYSIOLOGY OF PULMONARY-DISEASE IN CYSTIC-FIBROSIS
Authors: MARSHALL BC
Citation: Bc. Marshall, PATHOPHYSIOLOGY OF PULMONARY-DISEASE IN CYSTIC-FIBROSIS, Seminars in respiratory and critical care medicine, 15(5), 1994, pp. 364-374
INTERACTION OF SECRETORY LEUKOCYTE PROTEASE INHIBITOR WITH PROTEINASE-3
Authors: RAO NV MARSHALL BC GRAY BH HOIDAL JR
Citation: Nv. Rao et al., INTERACTION OF SECRETORY LEUKOCYTE PROTEASE INHIBITOR WITH PROTEINASE-3, American journal of respiratory cell and molecular biology, 8(6), 1993, pp. 612-616
METALLOPROTEINASES AND TISSUE INHIBITOR OF METALLOPROTEINASES IN MESOTHELIAL CELLS - CELLULAR-DIFFERENTIATION INFLUENCES EXPRESSION
Authors: MARSHALL BC SANTANA A XU QP PETERSEN MJ CAMPBELL EJ HOIDAL JR WELGUS HG
Citation: Bc. Marshall et al., METALLOPROTEINASES AND TISSUE INHIBITOR OF METALLOPROTEINASES IN MESOTHELIAL CELLS - CELLULAR-DIFFERENTIATION INFLUENCES EXPRESSION, The Journal of clinical investigation, 91(4), 1993, pp. 1792-1799
RAPID CYCLE ALLELE-SPECIFIC AMPLIFICATION - STUDIES WITH THE CYSTIC-FIBROSIS DELTA-F(508) LOCUS
Authors: WITTWER CT MARSHALL BC REED GH CHERRY JL
Citation: Ct. Wittwer et al., RAPID CYCLE ALLELE-SPECIFIC AMPLIFICATION - STUDIES WITH THE CYSTIC-FIBROSIS DELTA-F(508) LOCUS, Clinical chemistry, 39(5), 1993, pp. 804-809
Risultati: 1-9 |